Members

  First name: Marie-Helene
  Last name: Nicolas-Chanoine
  Email: marie-helene.nicolas-chanoine
._
_.
inserm.fr

Research interest



Exhaustive list of publications

2019


Nicolas-Chanoine MH, Vigan M, Laouénan C, Robert J, “cSG
Risk factors for carbapenem-resistant Enterobacteriaceae infections: a French case-control-control study.
European Journal of Clinical Microbiology & Infectious Diseases: Official Publication of the European Society of Clinical Microbiology 2019, 38, 383-393.

Melo LC, Haenni M, Saras E, Duprilot M, Nicolas-Chanoine MH, Madec JY
Emergence of the C1-M27 cluster in ST131 Escherichia coli from companion animals in France.
The Journal of Antimicrobial Chemotherapy 2019, 74, 3111-3113.

Birgy A, Levy C, Nicolas-Chanoine MH, Cointe A, Hobson CA, Magnan M, Bechet S, Bidet P, Cohen R, Bonacorsi S
Independent Host Factors and Bacterial Genetic Determinants of the Emergence and Dominance of Escherichia coli Sequence Type 131 CTX-M-27 in a Community Pediatric Cohort Study.
Antimicrobial Agents and Chemotherapy 2019, 63,

Flament-Simon SC, Duprilot M, Mayer N, García V, Alonso MP, Blanco J, Nicolas-Chanoine MH
Association Between Kinetics of Early Biofilm Formation and Clonal Lineage in Escherichia coli.
Frontiers in Microbiology 2019, 10, 1183.

2018


Lepelletier D, Bonnet R, Plésiat P, Nicolas-Chanoine MH, Berger-Carbonne A, Chidiac C, Grandbastien B, nwgftFHCoPH
Emergence of plasmid-mediated colistin resistance (mcr-1) among Enterobacteriaceae strains: Laboratory detection of resistance and measures to control its dissemination.
Medecine Et Maladies Infectieuses 2018, 48, 250-255.

Rossi B, Gasperini ML, Leflon-Guibout V, Gioanni A, de Lastours V, Rossi G, Dokmak S, Ronot M, Roux O, Nicolas-Chanoine MH, Fantin B, Lefort A
Hypervirulent Klebsiella pneumoniae in Cryptogenic Liver Abscesses, Paris, France.
Emerging Infectious Diseases 2018, 24, 221-229.

Nicolas-Chanoine MH, Mayer N, Guyot K, Dumont E, Pagès JM
Interplay Between Membrane Permeability and Enzymatic Barrier Leads to Antibiotic-Dependent Resistance in Klebsiella Pneumoniae.
Frontiers in Microbiology 2018, 9, 1422.

2017


Bialek-Davenet S, Mayer N, Vergalli J, Duprilot M, Brisse S, Pagès JM, Nicolas-Chanoine MH
In-vivo loss of carbapenem resistance by extensively drug-resistant Klebsiella pneumoniae during treatment via porin expression modification.
Scientific Reports 2017, 7, 6722.

Nicolas-Chanoine MH, Petitjean M, Mora A, Mayer N, Lavigne JP, Boulet O, Leflon-Guibout V, Blanco J, Hocquet D
The ST131 Escherichia coli H22 subclone from human intestinal microbiota: Comparison of genomic and phenotypic traits with those of the globally successful H30 subclone.
BMC microbiology 2017, 17, 71.

Robert J, Pantel A, Merens A, Meiller E, Lavigne JP, Nicolas-Chanoine MH, Ocrsg
Development of an algorithm for phenotypic screening of carbapenemase-producing Enterobacteriaceae in the routine laboratory.
BMC infectious diseases 2017, 17, 78.

2016


Sauget M, Cholley P, Vannier A, Thouverez M, Nicolas-Chanoine MH, Hocquet D, Bertrand X
Trends of extended-spectrum β-lactamase-producing Escherichia coli sequence type 131 and its H30 subclone in a French hospital over a 15-year period.
International Journal of Antimicrobial Agents 2016, 48, 744-747.

Fernández J, Bert F, Nicolas-Chanoine MH
The challenges of multi-drug-resistance in hepatology.
Journal of Hepatology 2016, 65, 1043-1054.

Aissa N, Mayer N, Bert F, Labia R, Lozniewski A, Nicolas-Chanoine MH
A new mechanism to render clinical isolates of Escherichia coli non-susceptible to imipenem: substitutions in the PBP2 penicillin-binding domain.
The Journal of Antimicrobial Chemotherapy 2016, 71, 76-79.

Pantel A, Dunyach-Remy C, Ngba Essebe C, Mesureur J, Sotto A, Pagès JM, Nicolas-Chanoine MH, Lavigne JP
Modulation of Membrane Influx and Efflux in Escherichia coli Sequence Type 131 Has an Impact on Bacterial Motility, Biofilm Formation, and Virulence in a Caenorhabditis elegans Model.
Antimicrobial Agents and Chemotherapy 2016, 60, 2901-2911.

Birgand G, Leroy C, Nerome S, Luong Nguyen LB, Lolom I, Armand-Lefevre L, Ciotti C, Lecorre B, Marcade G, Fihman V, Nicolas-Chanoine MH, Pelat C, Perozziello A, Fantin B, Yazdanpanah Y, Ricard JD, Lucet JC
Costs associated with implementation of a strict policy for controlling spread of highly resistant microorganisms in France.
BMJ open 2016, 6, e009029.

2015


Walckenaer E, Delmas J, Leflon-Guibout V, Bonnet R, Nicolas-Chanoine MH
Genetic, biochemical characterization and mutagenesis of the chromosomal class A β-lactamase of Raoultella (formerly Klebsiella) terrigena.
Pathologie-Biologie 2015, 63, 158-163.

Fam NS, Defasque S, Bert F, Leflon-Guibout V, El-Ray A, El-Ghannam M, Attia ME, Omar M, Desouki DG, Valla D, Nicolas-Chanoine MH
Faecal carriage of extended-spectrum β-lactamase (ESBL)-producing enterobacteria in liver disease patients from two hospitals in Egypt and France: a comparative epidemiological study.
Epidemiology and Infection 2015, 143, 1247-1255.

Bialek-Davenet S, Lavigne JP, Guyot K, Mayer N, Tournebize R, Brisse S, Leflon-Guibout V, Nicolas-Chanoine MH
Differential contribution of AcrAB and OqxAB efflux pumps to multidrug resistance and virulence in Klebsiella pneumoniae.
The Journal of Antimicrobial Chemotherapy 2015, 70, 81-88.

Madec JY, Haenni M, Métayer V, Saras E, Nicolas-Chanoine MH
High prevalence of the animal-associated bla CTX-M-1 IncI1/ST3 plasmid in human Escherichia coli isolates.
Antimicrobial Agents and Chemotherapy 2015, 59, 5860-5861.

2014


Lafolie J, Nicolas-Chanoine MH, Grenouillet F, Hocquet D, Bertrand X
Prevalence of Escherichia coli sequence type 131 and its H30 subclone among E. coli isolates in a French hospital.
International Journal of Antimicrobial Agents 2014, 44, 466-468.

Sauget M, Nicolas-Chanoine MH, Cabrolier N, Bertrand X, Hocquet D
Matrix-assisted laser desorption ionization-time of flight mass spectrometry assigns Escherichia coli to the phylogroups A, B1, B2 and D.
International journal of medical microbiology: IJMM 2014, 304, 977-983.

Bert F, Bialek-Davenet S, Leflon-Guibout V, Noussair L, Nicolas-Chanoine MH
Frequency and epidemiology of extended-spectrum β-lactamase-producing Enterobacteriaceae isolates susceptible to third-generation cephalosporins or to aztreonam.
Medecine Et Maladies Infectieuses 2014, 44, 76-78.

Blanc V, Leflon-Guibout V, Blanco J, Haenni M, Madec JY, Rafignon G, Bruno P, Mora A, Lopez C, Dahbi G, Dunais B, Anastay M, Branger C, Moreau R, Pradier C, Nicolas-Chanoine MH
Prevalence of day-care centre children (France) with faecal CTX-M-producing Escherichia coli comprising O25b:H4 and O16:H5 ST131 strains.
The Journal of Antimicrobial Chemotherapy 2014, 69, 1231-1237.

Robert J, Pantel A, Mérens A, Lavigne JP, Nicolas-Chanoine MH, OCRSG
Incidence rates of carbapenemase-producing Enterobacteriaceae clinical isolates in France: a prospective nationwide study in 2011-12.
The Journal of Antimicrobial Chemotherapy 2014, 69, 2706-2712.

Bialek-Davenet S, Criscuolo A, Ailloud F, Passet V, Nicolas-Chanoine MH, Decré D, Brisse S
Development of a multiplex PCR assay for identification of Klebsiella pneumoniae hypervirulent clones of capsular serotype K2.
Journal of Medical Microbiology 2014, 63, 1608-1614.

Liapis E, Pantel A, Robert J, Nicolas-Chanoine MH, Cavalié L, van der Mee-Marquet N, de Champs C, Aissa N, Eloy C, Blanc V, Guyeux C, Hocquet D, Lavigne JP, Bertrand X, O
Molecular epidemiology of OXA-48-producing Klebsiella pneumoniae in France.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2014, 20, O1121-1123.

Bert F, Larroque B, Dondero F, Durand F, Paugam-Burtz C, Belghiti J, Moreau R, Nicolas-Chanoine MH
Risk factors associated with preoperative fecal carriage of extended-spectrum β-lactamase-producing Enterobacteriaceae in liver transplant recipients.
Transplant Infectious Disease: An Official Journal of the Transplantation Society 2014, 16, 84-89.

Nicolas-Chanoine MH, Bertrand X, Madec JY
Escherichia coli ST131, an intriguing clonal group.
Clinical Microbiology Reviews 2014, 27, 543-574.

Bialek-Davenet S, Criscuolo A, Ailloud F, Passet V, Jones L, Delannoy-Vieillard AS, Garin B, Le Hello S, Arlet G, Nicolas-Chanoine MH, Decré D, Brisse S
Genomic definition of hypervirulent and multidrug-resistant Klebsiella pneumoniae clonal groups.
Emerging Infectious Diseases 2014, 20, 1812-1820.

2013


Lavigne JP, Sotto A, Nicolas-Chanoine MH, Bouziges N, Pagès JM, Davin-Regli A
An adaptive response of Enterobacter aerogenes to imipenem: regulation of porin balance in clinical isolates.
International Journal of Antimicrobial Agents 2013, 41, 130-136.

Bialek-Davenet S, Nicolas-Chanoine MH, Decré D, Brisse S
Microbiological and clinical characteristics of bacteraemia caused by the hypermucoviscosity phenotype of Klebsiella pneumoniae in Korea.
Epidemiology and Infection 2013, 141, 188.

Marcade G, Brisse S, Bialek S, Marcon E, Leflon-Guibout V, Passet V, Moreau R, Nicolas-Chanoine MH
The emergence of multidrug-resistant Klebsiella pneumoniae of international clones ST13, ST16, ST35, ST48 and ST101 in a teaching hospital in the Paris region.
Epidemiology and Infection 2013, 141, 1705-1712.

Johnson JR, Tchesnokova V, Johnston B, Clabots C, Roberts PL, Billig M, Riddell K, Rogers P, Qin X, Butler-Wu S, Price LB, Aziz M, Nicolas-Chanoine MH, Debroy C, Robicsek A, Hansen G, Urban C, Platell J, Trott DJ, Zhanel G, Weissman SJ, Cookson BT, Fang FC, Limaye AP, Scholes D, Chattopadhyay S, Hooper DC, Sokurenko EV
Abrupt emergence of a single dominant multidrug-resistant strain of Escherichia coli.
The Journal of Infectious Diseases 2013, 207, 919-928.

Nicolas-Chanoine MH, Gruson C, Bialek-Davenet S, Bertrand X, Thomas-Jean F, Bert F, Moyat M, Meiller E, Marcon E, Danchin N, Noussair L, Moreau R, Leflon-Guibout V
10-Fold increase (2006-11) in the rate of healthy subjects with extended-spectrum β-lactamase-producing Escherichia coli faecal carriage in a Parisian check-up centre.
The Journal of Antimicrobial Chemotherapy 2013, 68, 562-568.

Bialek-Davenet S, Leflon-Guibout V, Tran Minh O, Marcon E, Moreau R, Nicolas-Chanoine MH
Complete deletion of the ramR gene in an in vitro-selected mutant of Klebsiella pneumoniae overexpressing the AcrAB efflux pump.
Antimicrobial Agents and Chemotherapy 2013, 57, 672-673.

Blanco J, Mora A, Mamani R, López C, Blanco M, Dahbi G, Herrera A, Marzoa J, Fernández V, de la Cruz F, Martínez-Martínez L, Alonso MP, Nicolas-Chanoine MH, Johnson JR, Johnston B, López-Cerero L, Pascual A, Rodríguez-Baño J, SGfNI(
Four main virotypes among extended-spectrum-β-lactamase-producing isolates of Escherichia coli O25b:H4-B2-ST131: bacterial, epidemiological, and clinical characteristics.
Journal of Clinical Microbiology 2013, 51, 3358-3367.

Nicolas-Chanoine MH, Robert J, Vigan M, Laouénan C, Brisse S, Mentré F, Jarlier V, Cβsg
Different factors associated with CTX-M-producing ST131 and non-ST131 Escherichia coli clinical isolates.
PloS One 2013, 8, e72191.

2012


Maylin S, Laouénan C, Martinot-Peignoux M, Panhard X, Lapalus M, Nicolas-Chanoine MH, Bedossa P, Asselah T, Marcellin P
Role of hepatic HCV-RNA level on the severity of chronic hepatitis C and response to antiviral therapy.
Journal of Clinical Virology: The Official Publication of the Pan American Society for Clinical Virology 2012, 53, 43–47.

Lebeaux D, Zarrouk V, Petrover D, Nicolas-Chanoine MH, Fantin B
Salmonella Colindale osteomyelitis in an immunocompetent female patient.
Medecine Et Maladies Infectieuses 2012, 42, 36-37.

Lavigne JP, Sotto A, Nicolas-Chanoine MH, Bouziges N, Bourg G, Davin-Regli A, Pagès JM
Membrane permeability, a pivotal function involved in antibiotic resistance and virulence in Enterobacter aerogenes clinical isolates.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2012, 18, 539-545.

Brisse S, Diancourt L, Laouénan C, Vigan M, Caro V, Arlet G, Drieux L, Leflon-Guibout V, Mentré F, Jarlier V, Nicolas-Chanoine MH, CβSG
Phylogenetic distribution of CTX-M- and non-extended-spectrum-β-lactamase-producing Escherichia coli isolates: group B2 isolates, except clone ST131, rarely produce CTX-M enzymes.
Journal of Clinical Microbiology 2012, 50, 2974–2981.

Nicolas-Chanoine MH, Jarlier V, Robert J, Arlet G, Drieux L, Leflon-Guibout V, Laouénan C, Larroque B, Caro V, Mentré F, GCβ
Patient's origin and lifestyle associated with CTX-M-producing Escherichia coli: a case-control-control study.
PloS One 2012, 7, e30498.

Lavigne JP, Vergunst AC, Goret L, Sotto A, Combescure C, Blanco J, O'Callaghan D, Nicolas-Chanoine MH
Virulence potential and genomic mapping of the worldwide clone Escherichia coli ST131.
PloS One 2012, 7, e34294.

Johnson JR, Nicolas-Chanoine MH, DebRoy C, Castanheira M, Robicsek A, Hansen G, Weissman S, Urban C, Platell J, Trott D, Zhanel G, Clabots C, Johnston BD, Kuskowski MA, MI
Comparison of Escherichia coli ST131 pulsotypes, by epidemiologic traits, 1967-2009.
Emerging Infectious Diseases 2012, 18, 598-607.

Bert F, Larroque B, Paugam-Burtz C, Dondero F, Durand F, Marcon E, Belghiti J, Moreau R, Nicolas-Chanoine MH
Pretransplant fecal carriage of extended-spectrum β-lactamase-producing Enterobacteriaceae and infection after liver transplant, France.
Emerging Infectious Diseases 2012, 18, 908-916.

2011


Lucet JC, Nicolas-Chanoine MH, Lefort A, Roy C, Diamantis S, Papy E, Riveros-Palacios O, Le Grand J, Rioux C, Fantin B, Ravaud P
Do case vignettes accurately reflect antibiotic prescription?.
Infection Control and Hospital Epidemiology 2011, 32, 1003-1009.

Fam N, Leflon-Guibout V, Fouad S, Aboul-Fadl L, Marcon E, Desouky D, El-Defrawy I, Abou-Aitta A, Klena J, Nicolas-Chanoine MH
CTX-M-15-producing Escherichia coli clinical isolates in Cairo (Egypt), including isolates of clonal complex ST10 and clones ST131, ST73, and ST405 in both community and hospital settings.
Microbial Drug Resistance (Larchmont, N.Y.) 2011, 17, 67-73.

Lucet JC, Nicolas-Chanoine MH, Roy C, Riveros-Palacios O, Diamantis S, Le Grand J, Papy E, Rioux C, Fantin B, Lefort A, Ravaud P
Antibiotic use: knowledge and perceptions in two university hospitals.
The Journal of Antimicrobial Chemotherapy 2011, 66, 936-940.

Janny S, Bert F, Dondero F, Durand F, Guerrini P, Merckx P, Nicolas-Chanoine MH, Belghiti J, Mantz J, Paugam-Burtz C
Microbiological findings of culture-positive preservation fluid in liver transplantation.
Transplant Infectious Disease: An Official Journal of the Transplantation Society 2011, 13, 9-14.

Bert F, Huynh B, Dondero F, Johnson JR, Paugam-Burtz C, Durand F, Belghiti J, Valla D, Moreau R, Nicolas-Chanoine MH
Molecular epidemiology of Escherichia coli bacteremia in liver transplant recipients.
Transplant Infectious Disease: An Official Journal of the Transplantation Society 2011, 13, 359-365.

Sersté T, Bert F, Leflon-Guibout V, Chauvet C, Marcon E, Asselah T, Francoz C, Durand F, Lebrec D, Valla D, Moreau R, Nicolas-Chanoine MH
Detection of bacterial DNA in serum and ascitic fluid of asymptomatic outpatients with cirrhosis and non-neutrocytic ascites.
Liver International: Official Journal of the International Association for the Study of the Liver 2011, 31, 494-498.

Bialek-Davenet S, Marcon E, Leflon-Guibout V, Lavigne JP, Bert F, Moreau R, Nicolas-Chanoine MH
In vitro selection of ramR and soxR mutants overexpressing efflux systems by fluoroquinolones as well as cefoxitin in Klebsiella pneumoniae.
Antimicrobial Agents and Chemotherapy 2011, 55, 2795-2802.

2010


Jarlier V, Trystram D, Brun-Buisson C, Fournier S, Carbonne A, Marty L, Andremont A, Arlet G, Buu-Hoi A, Carlet J, Decré D, Gottot S, Gutmann L, Joly-Guillou ML, Legrand P, Nicolas-Chanoine MH, Soussy CJ, Wolf M, Lucet JC, Aggoune M, Brücker G, Régnier B, CdBVHdHUdldF
Curbing methicillin-resistant Staphylococcus aureus in 38 French hospitals through a 15-year institutional control program.
Archives of Internal Medicine 2010, 170, 552-559.

Bert F, Larroque B, Paugam-Burtz C, Janny S, Durand F, Dondero F, Valla DC, Belghiti J, Moreau R, Nicolas-Chanoine MH
Microbial epidemiology and outcome of bloodstream infections in liver transplant recipients: an analysis of 259 episodes.
Liver Transplantation: Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2010, 16, 393-401.

Bialek S, Lavigne JP, Chevalier J, Marcon E, Leflon-Guibout V, Davin A, Moreau R, Pagès JM, Nicolas-Chanoine MH
Membrane efflux and influx modulate both multidrug resistance and virulence of Klebsiella pneumoniae in a Caenorhabditis elegans model.
Antimicrobial Agents and Chemotherapy 2010, 54, 4373-4378.

Zarrouk V, Leflon-Guibout V, Robineaux S, Kalamarides M, Nicolas-Chanoine MH, Sterkers O, Fantin B
Broad-range 16S rRNA PCR with cerebrospinal fluid may be unreliable for management of postoperative aseptic meningitis.
Journal of Clinical Microbiology 2010, 48, 3331-3333.

Bert F, Johnson JR, Ouattara B, Leflon-Guibout V, Johnston B, Marcon E, Valla D, Moreau R, Nicolas-Chanoine MH
Genetic diversity and virulence profiles of Escherichia coli isolates causing spontaneous bacterial peritonitis and bacteremia in patients with cirrhosis.
Journal of Clinical Microbiology 2010, 48, 2709-2714.

2009


Lucet JC, Paoletti X, Demontpion C, Degrave M, Vanjak D, Vincent C, Andremont A, Jarlier V, Mentré F, Nicolas-Chanoine MH, SaRalMeHAD(HSG
Carriage of methicillin-resistant Staphylococcus aureus in home care settings: prevalence, duration, and transmission to household members.
Archives of Internal Medicine 2009, 169, 1372-1378.

Moucari R, Mackiewicz V, Lada O, Ripault MP, Castelnau C, Martinot-Peignoux M, Dauvergne A, Asselah T, Boyer N, Bedossa P, Valla D, Vidaud M, Nicolas-Chanoine MH, Marcellin P
Early serum HBsAg drop: a strong predictor of sustained virological response to pegylated interferon alfa-2a in HBeAg-negative patients.
Hepatology (Baltimore, Md.) 2009, 49, 1151-1157.

Mendonça N, Nicolas-Chanoine MH, Caniça M
Diversity of the bla(SHV) genes.
Diagnostic Microbiology and Infectious Disease 2009, 65, 439-446.

Moucari R, Korevaar A, Lada O, Martinot-Peignoux M, Boyer N, Mackiewicz V, Dauvergne A, Cardoso AC, Asselah T, Nicolas-Chanoine MH, Vidaud M, Valla D, Bedossa P, Marcellin P
High rates of HBsAg seroconversion in HBeAg-positive chronic hepatitis B patients responding to interferon: a long-term follow-up study.
Journal of Hepatology 2009, 50, 1084-1092.

Bert F, Leflon-Guibout V, Le Grand J, Bourdon N, Nicolas-Chanoine MH
[Emergence of vancomycin-dependent enterococci following glycopeptide therapy: case report and review].
Pathologie-Biologie 2009, 57, 56-60.

Blanco M, Alonso MP, Nicolas-Chanoine MH, Dahbi G, Mora A, Blanco JE, López C, Cortés P, Llagostera M, Leflon-Guibout V, Puentes B, Mamani R, Herrera A, Coira MA, García-Garrote F, Pita JM, Blanco J
Molecular epidemiology of Escherichia coli producing extended-spectrum {beta}-lactamases in Lugo (Spain): dissemination of clone O25b:H4-ST131 producing CTX-M-15.
The Journal of Antimicrobial Chemotherapy 2009, 63, 1135-1141.

Maylin S, Martinot-Peignoux M, Ripault MP, Moucari R, Cardoso AC, Boyer N, Giuily N, Castelnau C, Pouteau M, Asselah T, Nicolas-Chanoine MH, Marcellin P
Sustained virological response is associated with clearance of hepatitis C virus RNA and a decrease in hepatitis C virus antibody.
Liver International: Official Journal of the International Association for the Study of the Liver 2009, 29, 511-517.

Martinez-Medina M, Mora A, Blanco M, López C, Alonso MP, Bonacorsi S, Nicolas-Chanoine MH, Darfeuille-Michaud A, Garcia-Gil J, Blanco J
Similarity and divergence among adherent-invasive Escherichia coli and extraintestinal pathogenic E. coli strains.
Journal of Clinical Microbiology 2009, 47, 3968-3979.

Moucari R, Ripault MP, Martinot-Peignoux M, Voitot H, Cardoso AC, Stern C, Boyer N, Maylin S, Nicolas-Chanoine MH, Vidaud M, Valla D, Bedossa P, Marcellin P
Insulin resistance and geographical origin: major predictors of liver fibrosis and response to peginterferon and ribavirin in HCV-4.
Gut 2009, 58, 1662-1669.

Pages JM, Lavigne JP, Leflon-Guibout V, Marcon E, Bert F, Noussair L, Nicolas-Chanoine MH
Efflux pump, the masked side of beta-lactam resistance in Klebsiella pneumoniae clinical isolates.
PloS One 2009, 4, e4817.

Moucari R, Martinot-Peignoux M, Mackiewicz V, Boyer N, Ripault MP, Castelnau C, Leclere L, Dauvergne A, Valla D, Vidaud M, Nicolas-Chanoine MH, Marcellin P
Influence of genotype on hepatitis B surface antigen kinetics in hepatitis B e antigen-negative patients treated with pegylated interferon-alpha2a.
Antiviral Therapy 2009, 14, 1183-1188.

2008


Walckenaer E, Leflon-Guibout V, Nicolas-Chanoine MH
How to identify Raoultella spp. including R. ornithinolytica isolates negative for ornithine decarboxylase? The reliability of the chromosomal bla gene.
Journal of Microbiological Methods 2008, 75, 405-410.

Moucari R, Asselah T, Cazals-Hatem D, Voitot H, Boyer N, Ripault MP, Sobesky R, Martinot-Peignoux M, Maylin S, Nicolas-Chanoine MH, Paradis V, Vidaud M, Valla D, Bedossa P, Marcellin P
Insulin resistance in chronic hepatitis C: association with genotypes 1 and 4, serum HCV RNA level, and liver fibrosis.
Gastroenterology 2008, 134, 416-423.

Maylin S, Martinot-Peignoux M, Moucari R, Boyer N, Ripault MP, Cazals-Hatem D, Giuily N, Castelnau C, Cardoso AC, Asselah T, Féray C, Nicolas-Chanoine MH, Bedossa P, Marcellin P
Eradication of hepatitis C virus in patients successfully treated for chronic hepatitis C.
Gastroenterology 2008, 135, 821-829.

Nicolas-Chanoine MH, Blanco J, Leflon-Guibout V, Demarty R, Alonso MP, Caniça MM, Park YJ, Lavigne JP, Pitout J, Johnson JR
Intercontinental emergence of Escherichia coli clone O25:H4-ST131 producing CTX-M-15.
The Journal of Antimicrobial Chemotherapy 2008, 61, 273-281.

Yumuk Z, Afacan G, Nicolas-Chanoine MH, Sotto A, Lavigne JP
Turkey: a further country concerned by community-acquired Escherichia coli clone O25-ST131 producing CTX-M-15.
The Journal of Antimicrobial Chemotherapy 2008, 62, 284-288.

Nicolas-Chanoine MH, Jarlier V, 'CdBVHHdlPHdPF
Extended-spectrum beta-lactamases in long-term-care facilities.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2008, 14 Suppl 1, 111-116.

Bert F, Panhard X, Johnson J, Lecuyer H, Moreau R, Le Grand J, Johnston B, Sinègre M, Valla D, Nicolas-Chanoine MH
Genetic background of Escherichia coli isolates from patients with spontaneous bacterial peritonitis: relationship with host factors and prognosis.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2008, 14, 1034-1040.

Leflon-Guibout V, Blanco J, Amaqdouf K, Mora A, Guize L, Nicolas-Chanoine MH
Absence of CTX-M enzymes but high prevalence of clones, including clone ST131, among fecal Escherichia coli isolates from healthy subjects living in the area of Paris, France.
Journal of Clinical Microbiology 2008, 46, 3900-3905.

de Lastours V, Kalamarides M, Leflon V, Rodallec M, Vilgrain V, Nicolas-Chanoine MH, Fantin B
Optimization of bacterial diagnosis yield after needle aspiration in immunocompetent adults with brain abscesses.
Neurosurgery 2008, 63, 362-367; discussion 367-368.

Lavigne JP, Nicolas-Chanoine MH, Bourg G, Moreau J, Sotto A
Virulent synergistic effect between Enterococcus faecalis and Escherichia coli assayed by using the Caenorhabditis elegans model.
PloS One 2008, 3, e3370.

2007


Noussair L, Nicolas-Chanoine MH
[Obtention of bacterial antibiotic susceptibility following standard conditions directly from infected biological fluids and positive blood cultures].
Pathologie-Biologie 2007, 55, 143-148.

Poilane I, Bert F, Cruaud P, Nicolas-Chanoine MH, Collignon A
[Interest of the disk diffusion method for screening Clostridium difficile isolates with decreased susceptibility to antibiotics].
Pathologie-Biologie 2007, 55, 429-433.

Bert F, Vanjak D, Leflon-Guibout V, Mrejen S, Delpierre S, Redondo A, Nicolas-Chanoine MH
IMP-4-producing Pseudomonas aeruginosa in a French patient repatriated from Malaysia: impact of early detection and control measures.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2007, 44, 764-765.

Laurent F, Rodríguez-Nava V, Noussair L, Couble A, Nicolas-Chanoine MH, Boiron P
Nocardia ninae sp. nov., isolated from a bronchial aspirate.
International Journal of Systematic and Evolutionary Microbiology 2007, 57, 661-665.

2006


Heym B, Jouve F, Lemoal M, Veil-Picard A, Lortat-Jacob A, Nicolas-Chanoine MH
Pasteurella multocida infection of a total knee arthroplasty after a "dog lick".
Knee surgery, sports traumatology, arthroscopy: official journal of the ESSKA 2006, 14, 993-997.

2005


Ohana S, Leflon V, Ronco E, Rottman M, Guillemot D, Lortat-Jacob S, Denys P, Loubert G, Nicolas-Chanoine MH, Gaillard JL, Lawrence C
Spread of a Klebsiella pneumoniae strain producing a plasmid-mediated ACC-1 AmpC beta-lactamase in a teaching hospital admitting disabled patients.
Antimicrobial Agents and Chemotherapy 2005, 49, 2095-2097.

Heym B, Gehanno P, Friocourt V, Bougnoux ME, Le Moal M, Husson C, Leibowitch J, Nicolas-Chanoine MH
Molecular detection of Cellulosimicrobium cellulans as the etiological agent of a chronic tongue ulcer in a human immunodeficiency virus-positive patient.
Journal of Clinical Microbiology 2005, 43, 4269-4271.

2004


Heym B, Rimareix F, Lortat-Jacob A, Nicolas-Chanoine MH
Bacteriological investigation of infected pressure ulcers in spinal cord-injured patients and impact on antibiotic therapy.
Spinal Cord 2004, 42, 230-234.

Leflon-Guibout V, Jurand C, Bonacorsi S, Espinasse F, Guelfi MC, Duportail F, Heym B, Bingen E, Nicolas-Chanoine MH
Emergence and spread of three clonally related virulent isolates of CTX-M-15-producing Escherichia coli with variable resistance to aminoglycosides and tetracycline in a French geriatric hospital.
Antimicrobial Agents and Chemotherapy 2004, 48, 3736-3742.

Walckenaer E, Poirel L, Leflon-Guibout V, Nordmann P, Nicolas-Chanoine MH
Genetic and biochemical characterization of the chromosomal class A beta-lactamases of Raoultella (formerly Klebsiella) planticola and Raoultella ornithinolytica.
Antimicrobial Agents and Chemotherapy 2004, 48, 305-312.

2003


Granier SA, Plaisance L, Leflon-Guibout V, Lagier E, Morand S, Goldstein FW, Nicolas-Chanoine MH
Recognition of two genetic groups in the Klebsiella oxytoca taxon on the basis of chromosomal beta-lactamase and housekeeping gene sequences as well as ERIC-1 R PCR typing.
International Journal of Systematic and Evolutionary Microbiology 2003, 53, 661-668.

Armand-Lefèvre L, Leflon-Guibout V, Bredin J, Barguellil F, Amor A, Pagès JM, Nicolas-Chanoine MH
Imipenem resistance in Salmonella enterica serovar Wien related to porin loss and CMY-4 beta-lactamase production.
Antimicrobial Agents and Chemotherapy 2003, 47, 1165-1168.

Granier SA, Leflon-Guibout V, Goldstein FW, Nicolas-Chanoine MH
Enterobacterial repetitive intergenic consensus 1R PCR assay for detection of Raoultella sp. isolates among strains identified as Klebsiella oxytoca in the clinical laboratory.
Journal of Clinical Microbiology 2003, 41, 1740-1742.

Granier SA, Leflon-Guibout V, Goldstein FW, Nicolas-Chanoine MH
New Klebsiella oxytoca beta-lactamase genes bla(OXY-3) and bla(OXY-4) and a third genetic group of K oxytoca based on bla(OXY-3).
Antimicrobial Agents and Chemotherapy 2003, 47, 2922-2928.

Hanslik T, Hartig C, Jurand C, Armand-Lefevre L, Jubault V, Rouveix E, Dubourg O, Prinseau J, Baglin A, Nicolas-Chanoine MH
Clinical significance of tolerant strains of streptococci in adults with infective endocarditis.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2003, 9, 852-857.

2002


Leflon-Guibout V, Ternat G, Heym B, Nicolas-Chanoine MH
Exposure to co-amoxiclav as a risk factor for co-amoxiclav-resistant Escherichia coli urinary tract infection.
The Journal of Antimicrobial Chemotherapy 2002, 49, 367-371.

Leflon-Guibout V, Bonacorsi S, Clermont O, Ternat G, Heym B, Nicolas-Chanoine MH
Pyelonephritis caused by multiple clones of Escherichia coli, susceptible and resistant to co-amoxiclav, after a 45 day course of co-amoxiclav.
The Journal of Antimicrobial Chemotherapy 2002, 49, 373-377.

Granier SA, Nguyen Van JC, Kitzis MD, Goldstein FW, Leflon-Guibout V, Nicolas-Chanoine MH
First description of a TEM-30 (IRT-2)-producing Klebsiella oxytoca isolate.
Antimicrobial Agents and Chemotherapy 2002, 46, 1158-1159.

Granier SA, Leflon-Guibout V, Nicolas-Chanoine MH, Bush K, Goldstein FW
The extended-spectrum K1 beta-lactamase from Klebsiella oxytoca SC 10,436 is a member of the bla(OXY-2) family of chromosomal Klebsiella enzymes.
Antimicrobial Agents and Chemotherapy 2002, 46, 2056-2057.

Goëau-Brissonnière OA, Fabre D, Leflon-Guibout V, Di Centa I, Nicolas-Chanoine MH, Coggia M
Comparison of the resistance to infection of rifampin-bonded gelatin-sealed and silver/collagen-coated polyester prostheses.
Journal of Vascular Surgery 2002, 35, 1260-1263.

Sirot J, Nicolas-Chanoine MH, Chardon H, Avril JL, Cattoen C, Croix JC, Dabernat H, Fosse T, Ghnassia JC, Lecaillon E, Marmonier A, Roussel-Delvallez M, Soussy CJ, Trevoux A, Vandenesch F, Dib C, Moniot-Ville N, Rezvani Y
Susceptibility of Enterobacteriaceae to beta-lactam agents and fluoroquinolones: a 3-year survey in France.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2002, 8, 207-213.

Granier SA, Nicolas-Chanoine MH, Nguyen Van JC, Leflon-Guibout V, Kitzis MD, Goldstein FW
False susceptibility of Klebsiella oxytoca to some extended-spectrum cephalosporins.
The Journal of Antimicrobial Chemotherapy 2002, 50, 303-304.

Heym B, Le Moal M, Armand-Lefevre L, Nicolas-Chanoine MH
Multilocus sequence typing (MLST) shows that the 'Iberian' clone of methicillin-resistant Staphylococcus aureus has spread to France and acquired reduced susceptibility to teicoplanin.
The Journal of Antimicrobial Chemotherapy 2002, 50, 323-329.

Lartigue MF, Leflon-Guibout V, Poirel L, Nordmann P, Nicolas-Chanoine MH
Promoters P3, Pa/Pb, P4, and P5 upstream from bla(TEM) genes and their relationship to beta-lactam resistance.
Antimicrobial Agents and Chemotherapy 2002, 46, 4035-4037.

2001


Leclercq R, Nicolas-Chanoine MH, Nordmann P, Philippon A, Marchais P, Buu-Ho A, Chardon H, Dabernat H, Doucet-Populaire F, Grasmick C, Legrand P, Muller-Serieys C, Nguyen J, Ploy MC, Reverdy ME, Weber M, Courcol RJ
Multicenter evaluation of an automated system using selected bacteria that harbor challenging and clinically relevant mechanisms of resistance to antibiotics.
European Journal of Clinical Microbiology & Infectious Diseases: Official Publication of the European Society of Clinical Microbiology 2001, 20, 626-635.

2000


Cavallo JD, Fabre R, Leblanc F, Nicolas-Chanoine MH, Thabaut A, GddlRdPaaB
Antibiotic susceptibility and mechanisms of beta-lactam resistance in 1310 strains of pseudomonas aeruginosa: a French multicentre study (1996).
The Journal of Antimicrobial Chemotherapy 2000, 46, 133-136.

Soussy CJ, Carret G, Cavallo JD, Chardon H, Chidiac C, Choutet P, Courvalin P, Dabernat H, Drugeon H, Dubreuil L, Goldstein F, Jarlier V, Leclercq R, Nicolas-Chanoine MH, Philippon A, Quentin C, Rouveix B, Sirot J
[Antibiogram Committee of the French Microbiology Society. Report 2000-2001].
Pathologie-Biologie 2000, 48, 832-871.

Nicolas-Chanoine MH
Future needs--diagnostic services.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2000, 6, 423-425.

1999


Lelièvre H, Lina G, Jones ME, Olive C, Forey F, Roussel-Delvallez M, Nicolas-Chanoine MH, Bébéar CM, Jarlier V, Andremont A, Vandenesch F, Etienne J
Emergence and spread in French hospitals of methicillin-resistant Staphylococcus aureus with increasing susceptibility to gentamicin and other antibiotics.
Journal of Clinical Microbiology 1999, 37, 3452-3457.

1998


Speldooren V, Heym B, Labia R, Nicolas-Chanoine MH
Discriminatory detection of inhibitor-resistant beta-lactamases in Escherichia coli by single-strand conformation polymorphism-PCR.
Antimicrobial Agents and Chemotherapy 1998, 42, 879-884.

Swarén P, Maveyraud L, Raquet X, Cabantous S, Duez C, Pédelacq JD, Mariotte-Boyer S, Mourey L, Labia R, Nicolas-Chanoine MH, Nordmann P, Frère JM, Samama JP
X-ray analysis of the NMC-A beta-lactamase at 1.64-A resolution, a class A carbapenemase with broad substrate specificity.
The Journal of Biological Chemistry 1998, 273, 26714-26721.

1997


Leflon-Guibout V, Pons JL, Heym B, Nicolas-Chanoine MH
Typing of Clostridium perfringens strains by use of Random Amplified Polymorphic DNA (RAPD) system in comparison with zymotyping.
Anaerobe 1997, 3, 245-250.

Nicolas-Chanoine MH, Espinasse-Maes F
Evaluation of clonal relatedness of extended-spectrum beta-lactamase-producing Proteus mirabilis isolates by quantitative antibiogram and RAPD typing.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 1997, 3, 45-52.

Espinasse F, Gheorghiu R, Poiata A, Labia R, Nicolas-Chanoine MH
Reduced susceptibility to co-amoxiclav in Escherichia coli, Salmonella typhimurium and Klebsiella pneumoniae isolated in Romania between 1985 and 1993.
The Journal of Antimicrobial Chemotherapy 1997, 39, 103-106.

Nicolas-Chanoine MH
Inhibitor-resistant beta-lactamases.
The Journal of Antimicrobial Chemotherapy 1997, 40, 1-3.

Bougnoux ME, Dupont C, Turner L, Rouveix E, Dorra M, Nicolas-Chanoine MH
Mixed Candida glabrata and Candida albicans disseminated candidiasis in a heroin addict.
European Journal of Clinical Microbiology & Infectious Diseases: Official Publication of the European Society of Clinical Microbiology 1997, 16, 598-600.

1996


Nicolas-Chanoine MH
Impact of beta-lactamases on the clinical use of beta-lactam antibiotics.
International Journal of Antimicrobial Agents 1996, 7 Suppl 1, S21-26.

Mariotte-Boyer S, Nicolas-Chanoine MH, Labia R
A kinetic study of NMC-A beta-lactamase, an Ambler class A carbapenemase also hydrolyzing cephamycins.
FEMS microbiology letters 1996, 143, 29-33.

Dupont C, Turner L, Pinguet O, Leflon V, Rouveix E, Nicolas-Chanoine MH, Dorra M
[Staphylococcus lugdunensis endocarditis. A new case].
Annales De Medecine Interne 1996, 147, 374-375.

1989


Nicolas MH, Jarlier V, Honore N, Philippon A, Cole ST
Molecular characterization of the gene encoding SHV-3 beta-lactamase responsible for transferable cefotaxime resistance in clinical isolates of Klebsiella pneumoniae.
Antimicrobial Agents and Chemotherapy 1989, 33, 2096-2100.

1987


Nicolas MH, Honore N, Jarlier V, Philippon A, Cole ST
Molecular genetic analysis of cephalosporinase production and its role in beta-lactam resistance in clinical isolates of Enterobacter cloacae.
Antimicrobial Agents and Chemotherapy 1987, 31, 295-299.

1984


Nicolas MH, Jarlier V, Fievet MH, Nguyen J, Truffot C
[Resistance of Enterobacteria to cefotaxime and lamoxactam at the Pitié-Salpêtrière Hospital in 1982].
Pathologie-Biologie 1984, 32, 393-395.